AbbVie

Yahoo Finance • 21 hours ago

AbbVie Inc. (ABBV): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other Billionaire Ken Fisher’s h... Full story

Yahoo Finance • yesterday

AbbVie First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

AbbVie (NYSE:ABBV) First Quarter 2025 Results Key Financial Results Revenue: US$13.3b (up 8.4% from 1Q 2024). Net income: US$1.29b (down 5.4% from 1Q 2024). Profit margin: 9.6% (down from 11% in 1Q 2024). EPS: US$0.73 (down from US$0.77... Full story

Yahoo Finance • 2 days ago

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off

It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. Dividend-paying companies tend to have strong underlying operations and are generally m... Full story

Yahoo Finance • 2 days ago

China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz

The major averages were mixed near noon following several days of gains as investors process the latest batch of earnings reports, including a notable one from a big tech bellwether. Optimism over easing U.S.-China trade tensions, particul... Full story

Yahoo Finance • 2 days ago

AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ...

Adjusted Earnings Per Share (EPS): $2.46, $0.10 above guidance midpoint. Total Net Revenues: Over $13.3 billion, $550 million ahead of expectations. Ex-Humira Platform Sales Growth: More than 21% increase. Immunology Revenues: Over $6.2 bi... Full story

Yahoo Finance • 2 days ago

Q1 2025 AbbVie Inc Earnings Call

Participants Liz Shea; Senior Vice President, Investor Relations; AbbVie Inc Robert Michael; President, Chief Operating Officer; AbbVie Inc Jeffrey Stewart; Executive Vice President, Chief Commercial Officer; AbbVie Inc Roopal Thakkar;... Full story

Yahoo Finance • 3 days ago

How Much Would It Take To Earn $100 A Month From AbbVie Stock

AbbVie (NYSE:ABBV), a biopharmaceutical company, is engaged in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. It will report its Q1 2025 earnings on April 25, before the market... Full story

Yahoo Finance • 5 days ago

Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights – ABBV

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV during the class period listed ar... Full story

Yahoo Finance • 5 days ago

Why AbbVie Inc. (ABBV) is Among the Best Stocks That Will Always Grow

We recently published a list of 10 Best Stocks That Will Always Grow. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best stocks that will always grow. The Looming Risk of a Recession in... Full story

Yahoo Finance • 5 days ago

2 High-Yield Dividend Stocks to Buy for Passive Income

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting. The key is focusing on companies with strong yields, reliable payouts, and recession-re... Full story

Yahoo Finance • 7 days ago

Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a class action securities lawsuit. CLA... Full story

Yahoo Finance • 9 days ago

Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth?

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best pharma stocks to buy for long term growth. U.S. Pha... Full story

Yahoo Finance • 10 days ago

Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights – ABBV

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a class action securities lawsuit. CLA... Full story

Yahoo Finance • 10 days ago

Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best large-cap value stocks to buy as the reces... Full story

Yahoo Finance • 11 days ago

Investors who lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact The Gross Law Firm about pending Class Action - ABBV

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV during the class period listed ar... Full story

Yahoo Finance • 12 days ago

AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are gene... Full story

Yahoo Finance • 13 days ago

AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other high growth forever dividend stocks. Dividend stoc... Full story

Yahoo Finance • 15 days ago

Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?

We recently published a list of Long-Term Stock Portfolio: 15 Best Stocks for 15 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best stocks for 15 years. Russell Investments belie... Full story

Yahoo Finance • 17 days ago

Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. First quarter of 2025 witnessed sharp equities sell off... Full story

Yahoo Finance • 20 days ago

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Investing.com -- Goldman Sachs initiated coverage on several large-cap pharmaceutical companies, taking a cautious stance on Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), and AbbVie (NYSE:ABBV), while upgrading Eli Lilly (NYSE:LLY)... Full story